Singapore Specialty Generics Market Size & Outlook
Related Markets
Singapore specialty generics market highlights
- The Singapore specialty generics market generated a revenue of USD 532.4 million in 2022 and is expected to reach USD 1,131.7 million by 2030.
- The Singapore market is expected to grow at a CAGR of 9.9% from 2023 to 2030.
- In terms of segment, injectables was the largest revenue generating type in 2022.
- Injectables is the most lucrative type segment registering the fastest growth during the forecast period.
Specialty generics market data book summary
| Market revenue in 2022 | USD 532.4 million |
| Market revenue in 2030 | USD 1,131.7 million |
| Growth rate | 9.9% (CAGR from 2023 to 2030) |
| Largest segment | Injectables |
| Fastest growing segment | Injectables |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Injectables, Oral, Others Type |
| Key market players worldwide | Teva Pharmaceutical Industries Ltd, Viatris Inc, Novartis AG ADR, Hikma Pharmaceuticals PLC, Mallinckrodt PLC Ordinary Shares - New, Bausch Health Companies Inc, Dr. Reddy’s Laboratories, Endo Pharmaceuticals, Apotex Inc., Sun Pharmaceutical Industries, Fresenius Kabi AG, STADA Arzneimittel AG |
Other key industry trends
- In terms of revenue, Singapore accounted for 0.8% of the global specialty generics market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan specialty generics market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 5,895.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Specialty Generics Market Scope
Specialty Generics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| STADA Arzneimittel AG | View profile | 10001+ | Bad Vilbel, Hessen, Germany, Europe | http://stada.com |
| Fresenius Kabi AG | View profile | 10001+ | Bad Homburg, Hessen, Germany, Europe | https://www.fresenius-kabi.com |
| Apotex Inc. | View profile | 10001+ | Toronto, Ontario, Canada, North America | http://www.apotex.com |
| Hikma Pharmaceuticals PLC | View profile | 2150 | 1 New Burlington Place, London, United Kingdom, W1S 2HR | https://www.hikma.com |
| Bausch Health Companies Inc | View profile | 20270 | 2150 Saint Elzear Boulvard West, Laval, QC, Canada, H7L 4A8 | https://www.bauschhealth.com |
| Endo Pharmaceuticals | View profile | 1001-5000 | Ballsbridge, Dublin, Ireland, Europe | http://www.endo.com |
| Mallinckrodt PLC Ordinary Shares - New | View profile | 2700 | College Business and Technology Park, Cruiserath, Blanchardstown, Dublin, Ireland, 15 | https://www.mallinckrodt.com |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Dr. Reddy’s Laboratories | View profile | 10001+ | Hyderabad, Andhra Pradesh, India, Asia | http://www.drreddys.com/ |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.sunpharma.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Singapore specialty generics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to specialty generics market will help companies and investors design strategic landscapes.
Injectables was the largest segment with a revenue share of 64.35% in 2022. Horizon Databook has segmented the Singapore specialty generics market based on injectables, oral, others type covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Singapore specialty generics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Singapore specialty generics market databook
-
Our clientele includes a mix of specialty generics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Singapore specialty generics market , including forecasts for subscribers. This country databook contains high-level insights into Singapore specialty generics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Singapore Type - Specialty Generics Market size, 2022 - 2030 (US$M)
Singapore Specialty Generics Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
